Puretech Health Share Discussion Threads

[mach100] 27/8/2020 13:24

As the Rothchilds made their money by selling too soon I fully endorse PRTC selling down Karuna. Especially incrementally.

[volvo] 27/8/2020 10:43

The bonuses will be deemed earned when the share price reflects that success imo.

[edwardt] 27/8/2020 08:49

all i would say at 14 times their money on karuna - I think it fair to say it would be negligent if they didn't take the money. still nearly 10% left and royalties if they succeed. $400m cash pile will help pay those bonuses which i would argue might well have been actually earned.

[volvo] 27/8/2020 08:10

edward, the money will indeed be used to fund its internal drug pipeline...as well as to pay the very lucrative salaries and unlimited bonuses...cash burn is getting on for $90m per year.

As for Karuna, I wouldn't go near it, as its founded parent is bailing just as things a meant to be getting interesting there.

As always the caveat, with all things biotech, the landscape can change very quickly with any discovery. But for myself I am on the sidelines re Puretech.

[paulman10] 26/8/2020 14:47

Wheres that come from? Any upcoming catalysts? Was in at 150p.

[edwardt] 26/8/2020 13:53

they will spend it on funding internal projects, not sure what else everyone thinks they are going to do with it. It simply funds them far further out so they don't have to come cap in hand to shareholders anytime soon not on their terms. that seems sensible to me.

[the white house] 26/8/2020 13:37

Not impressed that they couldn't wait until January for another sale after huge amounts coming in recently WITHOUT giving strong ideas of what they are going to do with the dosh'

[edwardt] 26/8/2020 13:16

another $100m of cash hitting the b/s. nice.

[edwardt] 25/8/2020 15:35

anyone know what that leaves us in sonde? i don't think analysts have this at much value in their numbers? seems like a good one for an apple to buy outright for a couple of billion to me!

[rambutan2] 14/8/2020 14:59

Confirms that Daphne Z has big plans for PRTC, just have to be patient...




Mentioned by DZ:

(BBIO)

(SDGR)

(RPRX)

[rambutan2] 14/8/2020 14:51

Thanks edwardt - and they took the ticker MCRB!

[edwardt] 13/8/2020 07:08

Seres still flying stateside

[mach100] 11/8/2020 10:54

700k trade today at just under 280p. I think if that buyers holds on they will easily get 300p+ for the shares. 10% plus is not a bad return minus costs of course.

[edwardt] 11/8/2020 10:08

if prtc follows same flight path, vedanta could be half of market cap in short order! here's hoping!

[edwardt] 11/8/2020 08:19

for those not in the know vedanta is phase 2 for microbiome product for c diff reinfection risk. we are all looking at karuna - prtc has multiple moon shots. this one could be the next.

[edwardt] 11/8/2020 08:17

good readacross from seres on c difficile phase 3 results. even by my duff maths a move of $4 to $22 overnight is life changing for investors!

[zipstuck] 07/8/2020 08:40

Karuna now below $84

[volvo] 29/7/2020 10:20

rogers, I liked this stock and its cash pile, with the added side show of the listed Karuna...it became apparent when the directors took their share options in cash after a raft of good news to bolster the price first, at that stage it wasn't for me.


Still has plenty going on, like Karuna, Vedanta, Vor and its own pipeline could come good, but Akili can be copied, Gelesis run by Mrs Zohar's husband could point to Plenity being a diet fad, maybe a winner who knows, wasn't over keen either on the hair restorer and tropical scrub etc.

Anyhow good luck to all, as with all biotech, 1 blockbuster can change everything.

Ready to reinvest if the outlook changes.

[rogers49] 29/7/2020 08:40

Volvo, always interesting keep the chats coming.

[volvo] 29/7/2020 08:25

Well it was a smart move by the directors to cash in some Karuna shares ($350m) to fund their own pipeline of drugs and of course their expensive salaries, share options, pensions etc.

Karuna down $30 from its recent highs to $85, each dollar equates to approx $5m, so $150m down in a month.

[rambutan2] 24/7/2020 21:08

Fat profits aplenity for Gelesis!

Sheltering in place has led to serious weight gain of up to 16 pounds for 76 percent of Americans, says a new study commissioned by Nutrisystem, a commercial weight- loss product and service provider.

Another 63 percent of U.S. adults admitted they are now prioritizing post-quarantine weight loss to counteract the dietary choices they have made during the coronavirus lockdowns, which began in mid-March. Other difficulties the survey highlighted were that 42 percent of Americans have been struggling to stay physically active and maintain a consistent meal schedule while 34 percent are having a hard time staying motivated while they work from home.

[zipstuck] 20/7/2020 07:41

I still hold here. There have been a number of positive announcements since the company bought directors options. The company were in the know and the directors would not have wanted to sell options at discount. Always more risk on pharma's but then rewards are there.

[volvo] 17/7/2020 07:26

....Probably Jupiter asked for a leg up to shift some stock, who knows.

[volvo] 14/7/2020 07:50

The compelling investment case at 240p was the cash pile and Karuna shares....together they amounted to roughly the share value so you got all the 'fads' and a few serious drugs for free.

Karuna closed yesterday at $90...it was $115 just a few weeks ago, and we know cash burn is high. I also didnt like the management taking the share options in cash.

As for the Sunday Times tip, I normally run a mile from those things.

Probably Jupiter asked for a leg up to shift some stock, who knows.

I sold last week at 289p and taken a watching brief.